Shilpa Medicare Recalls Azacitidine Injection Due to Manufacturing Deviations
Shilpa Medicare Limited is voluntarily recalling 35,931 vials of Azacitidine for Injection due to Current Good Manufacturing Practice (CGMP) deviations.
- Product
- AZACITIDINE — AZACITIDINE (AZACITIDINE)
- Category
- Drug
- Distribution
- Distributed nationwide